OVER THE COUNTER ABUSE OF ANALGESICS- A SYSTEMATIC REVIEW

Main Article Content

Gubbala Dharani
Ilapakurthy Pavithra

Keywords

OTC analgesics, misuse, risk factors, regulation, public health, intervention strategies, healthcare professionals

Abstract

This research explores the misuse of over-the-counter (OTC) analgesics, which has become a growing concern due to the easy availability of these medications and a general lack of public awareness regarding their risks. The study highlights the primary risk factors for misuse, including peer pressure, curiosity, and pre-existing mental health or substance use issues. The health implications of OTC analgesic misuse can be severe, ranging from dependence and toxicity to potential overdose. Furthermore, the paper examines the role of pharmacists and healthcare providers in screening for misuse and implementing effective intervention strategies. Regulatory measures, such as limiting OTC analgesic sales and introducing prescription requirements for certain drugs, could help reduce misuse. Public education campaigns are also essential for raising awareness about the dangers of these medications. By providing insight into both the challenges and solutions, this research emphasizes the importance of a comprehensive approach to addressing OTC analgesic misuse. Future strategies should include stricter regulation, better educational outreach, and greater involvement from healthcare professionals to prevent misuse and promote responsible medication use.

Abstract 138 | PDF Downloads 91

References

1. Abbott F. V., Fraser M. I. Use and abuse of over-the-counter analgesic agents. Journal of Psychiatry & Neuroscience. 1998;23(1):13–34. [PMC free article] [PubMed] [Google Scholar]
2. Agaba E. I., Agaba P. A., Wigwe C. M. Use and abuse of analgesics in Nigeria: A community survey. Nigerian Journal of Medicine. 2004;13(4):379–382. [PubMed] [Google Scholar]
3. Ajuoga E., Sansgiry S. S., Ngo C., Yeh R. F. Use/misuse of over-the-counter medications and associated adverse drug events among HIV-infected patients. Research in Social & Administrative Pharmacy. 2008;4(3):292–301. doi: 10.1016/j.sapharm.2007.08.001. [DOI] [PubMed] [Google Scholar]
4. Akram G. Over-the-counter medication: An emerging and neglected drug abuse? Journal of Substance Use. 2000;5(2):136–142. [Google Scholar]
5. Akram G., Roberts K. Pharmacists’ management of over-the-counter medication requests from methadone patients. Journal of Substance Use. 2003;8(4):215–222. [Google Scholar]
6. Bond C. M., Bradley C. Over the counter drugs: The interface between the community pharmacist and patients. British Medical Journal. 1996;312(7033):758–760. doi: 10.1136/bmj.312.7033.758. [DOI] [PMC free article] [PubMed] [Google Scholar]
7. Bryant-Waugh R., Turner H., East P. Over-the-counter laxatives and eating disorders: A survey of pharmacists’ and other retailers’ views and practice. Pharmaceutical Journal. 2005;275:87–91. [Google Scholar]
8. Chetty R., Baoku Y., Mildner R., Banerjee A., Vallance D., Haddon A., Labib M. Severe hypokalaemia and weakness due to Nurofen misuse. Annals of Clinical Biochemistry. 2003;40(Pt. 4):422–423. doi: 10.1258/000456303766477101. [DOI] [PubMed] [Google Scholar]
9. Dean J., Rud F. The drug addict and the stigma of addiction. Substance Use & Misuse. 1984;19(8):859–869. doi: 10.3109/10826088409061991. [DOI] [PubMed] [Google Scholar]
10. Dobbin M., Tobin C. L. Over-the-counter ibuprofen/codeine analgesics: Misuse and harm. Melbourne, VIC: Drugs Policy and Services Branch Department of Human Services; 2008. [Google Scholar]
11. Dutch M. J. Nurofen plus misuse: An emerging cause of perforated gastric ulcer. Medical Journal of Australia. 2008;188(1):56–57. doi: 10.5694/j.1326-5377.2008.tb01509.x. [DOI] [PubMed] [Google Scholar]
12. Dyer B. T., Martin J. L., Mitchell J. L., Sauven N. C., Gazzard B. Hypokalaemia in ibuprofen and codeine phosphate abuse. International Journal of Clinical Practice. 2004;58(11):1061–1062. doi: 10.1111/j.1368-5031.2004.00304.x. [DOI] [PubMed] [Google Scholar]
13. Erickson C. K., Wilcox R. E. Please, not “Addiction” in DSM-V. The American Journal of Psychiatry. 2006;163(11):2015–2016. doi: 10.1176/ajp.2006.163.11.2015a. [DOI] [PubMed] [Google Scholar]
14. Ernest D., Chia M., Corallo C. E. Profound hypokalaemia due to Nurofen Plus and Red Bull misuse. Critical Care and Resuscitation. 2010;12(2):109–110. [PubMed] [Google Scholar]
15. Fox N., Ward K., O’Rourke A. The birth of the e-clinic. Continuity or transformation in the UK governance of pharmaceutical consumption? Social Science & Medicine. 2005;61(7):1474–1484. doi: 10.1016/j.socscimed.2005.03.011. [DOI] [PubMed] [Google Scholar]
16. Frei M. Y., Nielsen S., Dobbin M., Tobin C. L. Serious morbidity associated with misuse of over-the-counter codeine-ibuprofen analgesics: A series of 27 cases. Medical Journal of Australia. 2010;193(5):294–296. doi: 10.5694/j.1326-5377.2010.tb03911.x. [DOI] [PubMed] [Google Scholar]
17. Goffman E. Stigma: Notes on the management of spoiled identity. London: Penguin Group; 1990. [Google Scholar]
18. Gonzales R., Brecht M.-L., Mooney L., Rawson R. A. Prescription and over-the-counter drug treatment admissions to the California public treatment system. Journal of Substance Abuse Treatment. 2010;40(3):224–229. doi: 10.1016/j.jsat.2010.11.003. [DOI] [PMC free article] [PubMed] [Google Scholar]
19. Hughes G. F., Bell H. M., McElnay J. C. General practitioners’ awareness of the appropriate and inappropriate use of over-the-counter products. Pharmaceutical Journal. 1999a;263(7063):R29. [Google Scholar]
20. Hughes G. F., McElnay J. C., Hughes C. M., McKenna P. Abuse/misuse of non-prescription drugs. Pharmacy World & Science. 1999b;21(6):251–255. doi: 10.1023/a:1008788726842. [DOI] [PubMed] [Google Scholar]
21. Hughes J. R., Pillitteri J. L., Callas P. W., Callahan R., Kenny M. Misuse of and dependence on over-the-counter nicotine gum in a volunteer sample. Nicotine & Tobacco Research: Official Journal of the Society for Research on Nicotine and Tobacco. 2004;6(1):79–84. doi: 10.1080/14622200310001656894. [DOI] [PubMed] [Google Scholar]
22. Hughes L., Whittlesea C., Luscombe D. Patients’ knowledge and perceptions of the side-effects of OTC medication. Journal of Clinical Pharmacy Therapeutics. 2002;27:243–248. doi: 10.1046/j.1365-2710.2002.00416.x. [DOI] [PubMed] [Google Scholar]
23. Kanayama G., Gruber A. J., Pope H. G., Borowiecki J. J., Hudson J. I. Over-the-counter drug use in gymnasiums: An underrecognized substance abuse problem? Psychotherapy and Psychosomatics. 2001;70(3):137–140. doi: 10.1159/000056238. [DOI] [PubMed] [Google Scholar]
24. Lambert A. P., Close C. Life-threatening hypokalaemia from abuse of Nurofen Plus. Journal of the Royal Society of Medicine. 2005;98(1):21. doi: 10.1258/jrsm.98.1.21. [DOI] [PMC free article] [PubMed] [Google Scholar]
25. Lessenger J. E., Feinberg S. D. Abuse of prescription and over-the-counter medications. Journal of the American Board of Family Medicine. 2008;21(1):45–54. doi: 10.3122/jabfm.2008.01.070071. [DOI] [PubMed] [Google Scholar]
26. Levine D. A. “Pharming”: The abuse of prescription and over-the-counter drugs in teens. Current Opinion in Pediatrics. 2007;19(3):270–274. doi: 10.1097/MOP.0b013e32814b09cf. [DOI] [PubMed] [Google Scholar]
27. MacFadyen L., Eadie D., McGowan T. Community pharmacists’ experience of over-the-counter medicine misuse in Scotland. Journal of the Royal Society for the Promotion of Health. 2001;121(3):185–192. doi: 10.1177/146642400112100316. [DOI] [PubMed] [Google Scholar]
28. Major C., Vincze Z. Consumer habits and interests regarding non-prescription medications in Hungary. Family Practice. 2010;27(3):333–338. doi: 10.1093/fampra/cmp105. [DOI] [PubMed] [Google Scholar]
29. Matheson C., Bond C. M., Pitcairn J. Misuse of over-the-counter medicines from community pharmacies: A population survey of Scottish pharmacies. Pharmaceutical Journal. 2002;269(7206):66–68. [Google Scholar]
30. Mattoo S. K., Basu D., Sharma A., Balaji M., Malhotra A. Abuse of codeine-containing cough syrups: A report from India. Addiction. 1997;92(12):1783–1787. [PubMed] [Google Scholar]
31. McBride A. J., Pates R., Ramadan R., McGowan C. Delphi survey of experts’ opinions on strategies used by community pharmacists to reduce over-the-counter drug misuse. Addiction. 2003;98(4):487–497. doi: 10.1046/j.1360-0443.2003.00345.x. [DOI] [PubMed] [Google Scholar]
32. McIntosh J., Mckeganey N. Addicts’ narratives of recovery from drug use: Constructing a non-addict identity. Social Science & Medicine. 2000;50(10):1501–1510. doi: 10.1016/s0277-9536(99)00409-8. [DOI] [PubMed] [Google Scholar]
33. Murao S., Manabe H., Yamashita T., Sekikawa T. Intoxication with over-the-counter antitussive medication containing dihydrocodeine and chlorpheniramine causes generalized convulsion and mixed acidosis. Internal medicine (Tokyo, Japan) 2008;47(11):1013–1015. doi: 10.2169/internalmedicine.47.0925. [DOI] [PubMed] [Google Scholar]
34. Myers B., Siegfried N., Parry C. D. H. Over-the-counter and prescription medicine misuse in Cape Town – Findings from specialist treatment centres. South African Medical Journal. 2003;93(5):367–370. [PubMed] [Google Scholar]
35. Nettleton S. The Sociology of health and illness. Oxford: Polity; 2006. p. p. 352. [Google Scholar]
36. Nielsen S., Cameron J., Pahoki S. Over the counter codeine dependence final report 2010. Fitzroy, VIC: Turning Point Alcohol and Drug Centre; 2010. [Google Scholar]
37. O’Brien C. P., Volkow N., Li T. K. What’s in a word? Addiction versus dependence in DSM-V. American Journal of Psychiatry. 2006;163(5):764–765. doi: 10.1176/ajp.2006.163.5.764. [DOI] [PubMed] [Google Scholar]
38. Orriols L., Gaillard J., Lapeyre-Mestre M., Roussin A. Evaluation of abuse and dependence on drugs used for self-medication: A pharmacoepidemiological pilot study based on community pharmacies in France. Drug Safety. 2009;32(10):859–873. doi: 10.2165/11316590-000000000-00000. [DOI] [PubMed] [Google Scholar]
39. Pates R., McBride A. J., Li S., Ramadan R. Misuse of over-the-counter medicines: A survey of community pharmacies in the South Wales health authority. Pharmaceutical Journal. 2002;268(7184):179–182. [Google Scholar]
40. Paxton R., Chapple P. Misuse of over-the-counter medicines: A survey in one English county. Pharmaceutical Journal. 1996;256(6881):313–315. [Google Scholar]
41. Peters Jr., R., Yacoubian Jr., G. S., Rhodes W., Forsythe K. J., Bowers K. S., Eulian V. M., Mangum C. A., O’Neal J. D., Martin Q., Essien E. J. Beliefs and social norms about codeine and promethazine hydrochloride cough syrup (CPHCS) use and addiction among multi-ethnic college students. Journal of Psychoactive Drugs. 2007;39(3):277–282. doi: 10.1080/02791072.2007.10400614. [DOI] [PubMed] [Google Scholar]
42. Phelan M., Akram G. A community pharmacy-based survey of users of over-the-counter sleep aids. Pharmaceutical Journal. 2002;269(7213):287–290. [Google Scholar]
43. Raynor D., Blenkinsopp A., Knapp P., Grime J., Nicolson D., Pollock K., Dorer G., Gilbody S., Dickinson D., Maule A. J., Spoor P. A systematic review of quantitative and qualitative research on the role and effectiveness of written information available to patients about individual medicines. Health Technology Assessment. 2007;11(5):1–160. doi: 10.3310/hta11050. [DOI] [PubMed] [Google Scholar]
44. Reay G. An inquiry into physical dependence and addiction to prescription and over-the-counter medication. London: All-Party Parliamentary Drugs Misuse Group; 2009. [Google Scholar]
45. Reed K., Bond A., Witton J., Cornish R., Hickman M., Strang J. The changing use of prescribed benzodiazepines and z-drugs, & of over-the-counter codeine-containing products in England: A structured review of published English & international evidence & available data to inform consideration of the extent of dependence. London: The National Addiction Centre, Kings College London; 2011. [Google Scholar]
46. Reith G. Consumption and its discontents: Addiction, identity and the problems of freedom. British Journal of Sociology. 2004;55(2):283–300. doi: 10.1111/j.1468-4446.2004.00019.x. [DOI] [PubMed] [Google Scholar]
47. Robinson G. M., Robinson S., McCarthy P., Cameron C. Misuse of over-the-counter codeine-containing analgesics: Dependence and other adverse effects. New Zealand Medical Journal. 2010;123(1317):59–64. [PubMed] [Google Scholar]
48. Scottish Specialist in Pharmaceutical Public Health. Drugs misuse and community pharmacy: Issues for pharmaceutical care. Scotland: Scottish Specialist in Pharmaceutical Public Health; 2004. [Google Scholar]
49. Sproule B. A., Busto U. E., Somer G., Romach M. K., Sellers E. M. Characteristics of dependent and nondependent regular users of codeine. Journal of Clinical Psychopharmacology. 1999;19(4):367–372. doi: 10.1097/00004714-199908000-00014. [DOI] [PubMed] [Google Scholar]
50. Steinman K. High school students’ misuse of over-the-counter drugs: A population-based study in an urban county. Journal of Adolescent Health. 2006;38(4):445–447. doi: 10.1016/j.jadohealth.2005.08.010. [DOI] [PubMed] [Google Scholar]
51. Substance Abuse and Mental Health Services Administration, O. of A. S. The DASIS report. Characteristics of primary prescription and OTC treatment admissions: 2002. Rockville, MD: Substance Abuse and Mental Health Services Administration; 2004. [Google Scholar]
52. Substance Abuse and Mental Health Services Administration, O. of A. S. The NSDUH report: Misuse of over-the-counter cough and cold medications among persons aged 12 to 25. Rockville, MD: Substance Abuse and Mental Health Services Administration; 2008. [Google Scholar]
53. Substance Abuse and Mental Health Services Administration, O. of A. S. Drug abuse warning network, 2007: National estimates of drug-related emergency department visits. Rockville, MD: Substance Abuse and Mental Health Services Administration; 2010. [Google Scholar]
54. Sweileh W. M., Arafat R. T., Al-Khyat L. S., Al-Masri D. M., Jaradat N. A. A pilot study to investigate over-the-counter drug abuse and misuse in Palestine. Saudi Medical Journal. 2004;25(12):2029–2032. [PubMed] [Google Scholar]
55. Temple D. A “harm reduction” model for community pharmacy. Chemist-and-Druggist. 1996;245:730–773. [Google Scholar]
56. Temple D. Misuse of over the counter medicines in the UK. In: Sheridan J., Strang J., editors. Drug misuse and community pharmacy. London: Taylor and Francis; 2003. pp. 149–160. [Google Scholar]
57. Tinsley J. A., Watkins D. D. Over-the-counter stimulants: Abuse and addiction. Mayo Clinic Proceedings. 1998;73(10):977–982. doi: 10.4065/73.10.977. [DOI] [PubMed] [Google Scholar]
58. Wazaify M., Hughes C. M., McElnay J. C. The implementation of a harm minimisation model for the identification and treatment of over-the-counter drug misuse and abuse in community pharmacies in Northern Ireland. Patient Education and Counseling. 2006;64(1–3):136–141. doi: 10.1016/j.pec.2005.12.008. [DOI] [PubMed] [Google Scholar]
59. Wazaify M., Shields E., Hughes C. M., McElnay J. C. Societal perspectives on over-the-counter (OTC) medicines. Family Practice. 2005;22(2):170–171. doi: 10.1093/fampra/cmh723. [DOI] [PubMed] [Google Scholar]
60. Williams J. F., Kokotailo P. K. Abuse of proprietary (over-the-counter) drugs. Adolescent Medicine Clinics. 2006;17(3):733–750. doi: 10.1016/j.admecli.2006.06.006. Abstract xiii. [DOI] [PubMed] [Google Scholar]